Nanoemulsion Market Report by Type (Small-molecule Surfactant, Protein-stabilized Emulsions, Polysaccharide), Route of Administration (Oral, Parenteral, and Others), Application (Anesthetics, Antibiotics, Nonsteroidal Anti-inflammatory Drugs, Immunosuppressants, Steroids, and Others), and Region 2024-2032
The global nanoemulsion market size reached US$ 11.6 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 22.8 Billion by 2032, exhibiting a growth rate (CAGR) of 7.5% during 2024-2032.
Market Size in 2023
US$ 11.6 Billion
Market Forecast in 2032
US$ 22.8 Billion
Market Growth Rate 2024-2032
Nanoemulsions are thermodynamically stable isotropic systems wherein two immiscible liquids are mixed using an emulsifying agent like surfactant and co-surfactant. They are safe, effective, non-toxic, and non-irritant and have small-sized droplets with a greater surface area that provide better absorption and improved physical stability. As a result, they are used as carriers of drug molecules in pharmaceutical systems to improve the delivery of active pharma ingredients. They also help protect drugs that are susceptible to hydrolysis and oxidation, enable prolonged action of the medicaments, and provide better uptake of oil-soluble supplements in cell culture technology.
Nanoemulsion Market Trends:
The rising prevalence of chronic diseases, along with increasing preferences for smart and precision drug delivery systems, represents one of the key factors catalyzing the demand for nanoemulsions worldwide. Moreover, nanoemulsions are used for targeted drug delivery of various anticancer drugs, photosensitizers, and therapeutic agents. In addition, as they can enhance the therapeutic efficacy of drugs and minimize adverse effects and toxic reactions, they are gaining traction over conventional drug delivery systems across the globe. Apart from this, the growing aging population, which is more susceptible to critical health disorders, is propelling the need for nanoemulsions to treat reticuloendothelial system (RES) infection and in the enzyme replacement therapy of the liver. Besides this, they are employed in the cosmetics and personal care industries to manufacture foams, creams, liquids, and sprays. Furthermore, increasing demand for functional food on account of the rising health consciousness among individuals is positively influencing the applications of nanoemulsions in the food and beverage (F&B) industry. They assist in improving the digestibility of food and the bioavailability of active components.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global nanoemulsionmarket report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on type, route of administration and application.
Breakup by Type:
Breakup by Route of Administration:
Breakup by Application:
Nonsteroidal Anti-inflammatory Drugs
Breakup by Region:
Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being Ascendia Pharmaceuticals, B. Braun Melsungen AG, BlueWillow Biologics Inc., Covaris Inc., Fresenius Kabi AG, IDEX Corporation, Kaken Pharmaceutical Co. Ltd., Latitude Pharmaceuticals Inc., Owen Biosciences Inc., Santen Pharmaceutical Co. Ltd and Taiwan Liposome Co. Ltd.
Base Year of the Analysis
Type, Route of Administration, Application, Region
Asia Pacific, Europe, North America, Latin America, Middle East and Africa
United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Ascendia Pharmaceuticals, B. Braun Melsungen AG, BlueWillow Biologics Inc., Covaris Inc., Fresenius Kabi AG, IDEX Corporation, Kaken Pharmaceutical Co. Ltd., Latitude Pharmaceuticals Inc., Owen Biosciences Inc., Santen Pharmaceutical Co. Ltd and Taiwan Liposome Co. Ltd.
10% Free Customization
Report Price and Purchase Option
Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
Post-Sale Analyst Support
PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)
Key Questions Answered in This Report
The global nanoemulsion market was valued at US$ 11.6 Billion in 2023.
We expect the global nanoemulsion market to exhibit a CAGR of 7.5% during 2024-2032.
The rising prevalence of several chronic diseases, along with increasing demand for nanoemulsion to enhance the therapeutic efficacy of drugs and minimize adverse effects and toxic reactions, is primarily driving the global nanoemulsion market.
The sudden outbreak of the COVID-19 pandemic has led to the growing adoption of nanoemulsion across the healthcare sector for developing the coronavirus infection vaccine.
Based on the type, the global nanoemulsion market has been segregated into small-molecule surfactant, protein-stabilized emulsions, and polysaccharide. Among these, small-molecule surfactant currently holds the largest market share.
Based on the application, the global nanoemulsion market can be bifurcated into anesthetics, antibiotics, nonsteroidal anti-inflammatory drugs, immunosuppressants, steroids, and others. Currently, immunosuppressants exhibit a clear dominance in the market.
On a regional level, the market has been classified into North America, Asia-Pacific, Europe, Latin America, and Middle East and Africa, where North America currently dominates the global market.
Some of the major players in the global nanoemulsion market include Ascendia Pharmaceuticals, B. Braun Melsungen AG, BlueWillow Biologics Inc., Covaris Inc., Fresenius Kabi AG, IDEX Corporation, Kaken Pharmaceutical Co. Ltd., Latitude Pharmaceuticals Inc., Owen Biosciences Inc., Santen Pharmaceutical Co. Ltd, and Taiwan Liposome Co. Ltd.
Need more help?
Speak to our experienced analysts for insights on the current market scenarios.
Include additional segments and countries to customize the report as per your requirement.
Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
For further assistance, please connect with our analysts.
Gain a deeper dive into a specific application, geography, customer, or competitor
Any level of personalization
Get in Touch With Us
IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.
The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required
We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra
The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.
I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.
We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.